5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | NEUTRAL | BUY | SELL | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 8.56▲ | 8.56▲ | 8.56▲ | 9.20▼ | 8.81▲ |
MA10 | 8.93▼ | 9.23▼ | 9.14▼ | 9.21▼ | 8.73▲ |
MA20 | 9.84▼ | 9.06▼ | 8.69▲ | 8.87▼ | 8.26▲ |
MA50 | 9.15▼ | 8.16▲ | 7.99▲ | 8.57▲ | 8.55▲ |
MA100 | 8.40▲ | 7.96▲ | 7.90▲ | 8.07▲ | 13.17▼ |
MA200 | 8.15▲ | 8.00▲ | 8.31▲ | 8.42▲ | 183.94▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.224▼ | -0.160▼ | -0.084▼ | -0.030▼ | 0.176▲ |
RSI | 43.547▼ | 51.688▲ | 54.258▲ | 49.326▼ | 51.812▲ |
STOCH | 12.992▼ | 8.512▼ | 11.555▼ | 51.848 | 45.517 |
WILL %R | -75.851▼ | -77.244▼ | -70.674 | -56.989 | -51.667 |
CCI | -38.084 | -39.393 | -18.330 | -57.415 | 61.180 |
Tuesday, June 24, 2025 10:01 PM
Geneva, Switzerland, June 25, 2025-Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development ...
|
Thursday, June 19, 2025 08:01 PM
Addex Therapeutics Ltd (NASDAQ:ADXN) needs to conduct further studies to optimize the use of dipraglurant in post-stroke rehabilitation, indicating a longer timeline before potential market entry.
|
Wednesday, June 18, 2025 10:29 PM
(RTTNews) - Addex Therapeutics Ltd. (ADXN) reported Thursday narrower net loss in its first quarter on the absence of prior year's loss from discontinued operations and lower expenses, despite ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
11/07/25 | 9.05 | 9.10 | 8.83 | 8.83 | 5,987 |
10/07/25 | 8.78 | 9.266 | 8.78 | 8.94 | 2,923 |
09/07/25 | 9.13 | 9.4434 | 8.91 | 9.2897 | 5,294 |
08/07/25 | 9.48 | 9.48 | 9.48 | 9.48 | 290 |
07/07/25 | 9.08 | 9.48 | 9.0478 | 9.48 | 884 |
03/07/25 | 9.69 | 9.89 | 8.99 | 9.375 | 28,993 |
02/07/25 | 9.05 | 9.80 | 9.05 | 9.13 | 14,879 |
01/07/25 | 9.54 | 9.87 | 8.99 | 9.20 | 44,100 |
30/06/25 | 9.175 | 9.80 | 8.80 | 9.41 | 51,904 |
27/06/25 | 9.25 | 9.80 | 8.50 | 9.0017 | 60,692 |
|
|
||||
|
|
||||
|
|